Ariel Ramírez-Labrada

1.1k total citations
28 papers, 740 citations indexed

About

Ariel Ramírez-Labrada is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Ariel Ramírez-Labrada has authored 28 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 13 papers in Immunology and 10 papers in Molecular Biology. Recurrent topics in Ariel Ramírez-Labrada's work include Cancer Immunotherapy and Biomarkers (10 papers), Immune Cell Function and Interaction (9 papers) and CAR-T cell therapy research (7 papers). Ariel Ramírez-Labrada is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Immune Cell Function and Interaction (9 papers) and CAR-T cell therapy research (7 papers). Ariel Ramírez-Labrada collaborates with scholars based in Spain, France and Italy. Ariel Ramírez-Labrada's co-authors include Julián Pardo, Maykel Arias, Eva M. Gálvez, Dolores Isla, Antonio Rezusta, Á. Artal, Luis Martínez‐Lostao, Llipsy Santiago, Alberto Anel and Isabel Marzo and has published in prestigious journals such as Cancer Cell, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Ariel Ramírez-Labrada

25 papers receiving 734 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ariel Ramírez-Labrada Spain 15 325 296 293 107 96 28 740
A. Nazmul H. Khan United States 14 406 1.2× 451 1.5× 251 0.9× 68 0.6× 43 0.4× 19 844
Takeshi Otani Japan 15 316 1.0× 411 1.4× 180 0.6× 65 0.6× 65 0.7× 48 889
Alex Abel United States 7 262 0.8× 632 2.1× 285 1.0× 77 0.7× 42 0.4× 12 978
Curtis J. Henry United States 16 272 0.8× 433 1.5× 213 0.7× 51 0.5× 42 0.4× 49 887
Kohei Tada Japan 15 220 0.7× 158 0.5× 242 0.8× 66 0.6× 42 0.4× 33 594
Susan D. Mertins United States 11 479 1.5× 170 0.6× 236 0.8× 95 0.9× 64 0.7× 16 797
Arezoo Hosseini Iran 16 239 0.7× 393 1.3× 258 0.9× 56 0.5× 62 0.6× 28 935
Rossella Fasano Italy 13 185 0.6× 146 0.5× 178 0.6× 61 0.6× 85 0.9× 20 522
Kotaro Miyake Japan 14 342 1.1× 205 0.7× 328 1.1× 125 1.2× 120 1.3× 59 864

Countries citing papers authored by Ariel Ramírez-Labrada

Since Specialization
Citations

This map shows the geographic impact of Ariel Ramírez-Labrada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ariel Ramírez-Labrada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ariel Ramírez-Labrada more than expected).

Fields of papers citing papers by Ariel Ramírez-Labrada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ariel Ramírez-Labrada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ariel Ramírez-Labrada. The network helps show where Ariel Ramírez-Labrada may publish in the future.

Co-authorship network of co-authors of Ariel Ramírez-Labrada

This figure shows the co-authorship network connecting the top 25 collaborators of Ariel Ramírez-Labrada. A scholar is included among the top collaborators of Ariel Ramírez-Labrada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ariel Ramírez-Labrada. Ariel Ramírez-Labrada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Domingo, María Pilar, María del Mar Encabo-Berzosa, Ariel Ramírez-Labrada, et al.. (2025). Combination of exhaled volatile organic compounds with serum biomarkers predicts respiratory infection severity. Pulmonology. 31(1). 2477911–2477911.
2.
Ramírez-Labrada, Ariel, Luis Martínez‐Lostao, María Pilar Domingo, et al.. (2024). Biomarkers of Immunotherapy Response in Patients with Non-Small-Cell Lung Cancer: Microbiota Composition, Short-Chain Fatty Acids, and Intestinal Permeability. Cancers. 16(6). 1144–1144. 6 indexed citations
3.
Ramírez-Labrada, Ariel, Llipsy Santiago, Maykel Arias, et al.. (2024). Multiparametric in vitro and in vivo analysis of the safety profile of self-assembling peptides. Scientific Reports. 14(1). 4395–4395. 4 indexed citations
4.
Martínez‐Lostao, Luis, Maykel Arias, Eva M. Gálvez, et al.. (2024). CAR Immunotherapy for the treatment of infectious diseases: a systematic review. Frontiers in Immunology. 15. 1289303–1289303. 20 indexed citations
5.
Ramírez-Labrada, Ariel, Luis Martínez‐Lostao, José Ramón Paño‐Pardo, et al.. (2023). A Subset of PD-1-Expressing CD56bright NK Cells Identifies Patients with Good Response to Immune Checkpoint Inhibitors in Lung Cancer. Cancers. 15(2). 329–329. 12 indexed citations
6.
Martínez‐Domínguez, Samuel J., Sandra G. García, Carla J. Gargallo-Puyuelo, et al.. (2023). Unravelling the cellular response to the SARS-COV-2 vaccine in inflammatory bowel disease patients on biologic drugs. Scientific Reports. 13(1). 23061–23061.
7.
Ramírez-Labrada, Ariel, Llipsy Santiago, Carmen Oñate, et al.. (2022). All About (NK Cell-Mediated) Death in Two Acts and an Unexpected Encore: Initiation, Execution and Activation of Adaptive Immunity. Frontiers in Immunology. 13. 896228–896228. 67 indexed citations
8.
Lanuza, Pilar M., M. Henar Alonso, Iratxe Uranga-Murillo, et al.. (2022). Adoptive NK Cell Transfer as a Treatment in Colorectal Cancer Patients: Analyses of Tumour Cell Determinants Correlating With Efficacy In Vitro and In Vivo. Frontiers in Immunology. 13. 890836–890836. 12 indexed citations
9.
Uranga-Murillo, Iratxe, Ariel Ramírez-Labrada, Llipsy Santiago, et al.. (2021). Biological relevance of Granzymes A and K during E. coli sepsis. Theranostics. 11(20). 9873–9883. 14 indexed citations
10.
Uranga-Murillo, Iratxe, Sandra García‐Mulero, José Luis Sierra-Monzón, et al.. (2021). Integrated analysis of circulating immune cellular and soluble mediators reveals specific COVID19 signatures at hospital admission with utility for prediction of clinical outcomes. Theranostics. 12(1). 290–306. 12 indexed citations
11.
Isla, Dolores, Eva M. Gálvez, José Ramón Paño, et al.. (2020). Intratumoral versus Circulating Lymphoid Cells as Predictive Biomarkers in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Is the Easiest Path the Best One?. Cells. 9(6). 1525–1525. 16 indexed citations
12.
Pardo, Julián, Eva M. Gálvez, Dolores Isla, et al.. (2020). From Tumor Mutational Burden to Blood T Cell Receptor: Looking for the Best Predictive Biomarker in Lung Cancer Treated with Immunotherapy. Cancers. 12(10). 2974–2974. 20 indexed citations
13.
Arias, Maykel, José Luis Sierra-Monzón, Llipsy Santiago, et al.. (2020). The Multifaceted Function of Granzymes in Sepsis: Some Facts and a Lot to Discover. Frontiers in Immunology. 11. 1054–1054. 32 indexed citations
14.
Ramírez-Labrada, Ariel, Dolores Isla, Á. Artal, et al.. (2020). The Influence of Lung Microbiota on Lung Carcinogenesis, Immunity, and Immunotherapy. Trends in cancer. 6(2). 86–97. 164 indexed citations
15.
16.
Martínez‐Lostao, Luis, Ariel Ramírez-Labrada, José Ramón Paño, et al.. (2020). Microbiota and Lung Cancer. Opportunities and Challenges for Improving Immunotherapy Efficacy. Frontiers in Oncology. 10. 568939–568939. 19 indexed citations
17.
Parvin, Salma, Ariel Ramírez-Labrada, Shlomzion Aumann, et al.. (2019). LMO2 Confers Synthetic Lethality to PARP Inhibition in DLBCL. Cancer Cell. 36(3). 237–249.e6. 48 indexed citations
18.
Ramírez-Labrada, Ariel, Patricia Galán‐Malo, Gemma Azaceta, et al.. (2014). Two death pathways induced by sorafenib in myeloma cells: Puma-mediated apoptosis and necroptosis. Clinical & Translational Oncology. 17(2). 121–132. 22 indexed citations
19.
Sánchez‐Martínez, Diego, Ewelina Krzywińska, Moeez Rathore, et al.. (2014). All-trans retinoic acid (ATRA) induces miR-23a expression, decreases CTSC expression and granzyme B activity leading to impaired NK cell cytotoxicity. The International Journal of Biochemistry & Cell Biology. 49. 42–52. 38 indexed citations
20.
Ramírez-Labrada, Ariel, et al.. (1999). La aspirina. El medicamento del siglo. Revista Archivo Médico de Camagüey. 3(3). 0–0.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Nazmul H. Khan Breakdown of academic impact, for papers by Takeshi Otani Breakdown of academic impact, for papers by Alex Abel Breakdown of academic impact, for papers by Curtis J. Henry Breakdown of academic impact, for papers by Kohei Tada Breakdown of academic impact, for papers by Susan D. Mertins Breakdown of academic impact, for papers by Arezoo Hosseini Breakdown of academic impact, for papers by Rossella Fasano Breakdown of academic impact, for papers by Kotaro Miyake
Rankless by CCL
2026